Andreu Climent, nominated to the EIT Innovators Award

As every year, the European Institute of Innovation & Technology has made public the candidates for its annual awards.

Among this year’s list of nominees is Andreu Climent, CEO of CorifyCare and researcher at the ITACA Institute, nominated by EIT Health in the category of innovators, representing the AF-FINE innovation project and the ACORYS® device, a medical device that combines software and hardware to help with the diagnosis and treatment of heart rhythm disorder.

ACORYS® is the first real-time measurement solution of Atrial Fibrillation (AF) complexity that can stratify AF patients, predict the ablation efficacy, and provide a guide for AF driver ablation.

Atrial Fibrillation (AF) is a pathology that doubles the probability of suffering a stroke. More than 90% of people cannot benefit from the most effective treatment (i.e. cardiac ablation) due to difficulties in identifying the atrial regions in a non-invasive way. This is the first medical device that can show the degree of electrical damage of the atria in a patient during a regular visit. It increases AF treatment efficacy from around 50% to 95% and reduces AF treatment costs by around 40%. It also reduces investment costs by over 50% compared to alternatives.

EIT Health has been fundamental in showing the research team the flowchart from research to market. The network has provided introductions to many experts in areas including investment, management, production, regulation, and market access, which are helping to build a team that makes the innovation progress and succeed.

To vote for Andreu: https://eit.europa.eu/eit-awards-2020/nominees/eit-health-andreu-martinez-climent-es

Sources: EIT and EIT Health